Table 3.
Relationships of Serum I-FABP With Measures of Body Composition in Individuals With Chronic HIV and HIV-Negative Controls
| Chronic HIV, Spearman ρ | P Value | HIV-Negative, Spearman ρ | P Value | |
|---|---|---|---|---|
| BMI | –.36 | <.0001 | .11 | .37 |
| VAT | –.28 | .0005 | –.07 | .57 |
| SAT | –.24 | .003 | .12 | .34 |
| Total body fat | –.26 | .001 | .08 | .50 |
| Total body fat | –.15 | .07 | .11 | .39 |
| Total lean body mass | –.21 | .008 | –.05 | .70 |
| Total mass | –.33 | <.0001 | .06 | .64 |
Abbreviations: BMI, body mass index; I-FABP, intestinal fatty acid binding protein; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.